SG Americas Securities
GH icon

SG Americas Securities’s Guardant Health GH Stock Holding History

SG Americas Securities’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.44M Buy
36,270
+14,026
+63% +$1.53M ﹤0.01% 1055
2026
Q1 		$2.06M Buy
22,244
+5,197
+30% +$522K ﹤0.01% 1383
2025
Q4 		$1.74M Buy
+17,047
New +$1.52M ﹤0.01% 1618
2025
Q3 		– Sell
-3,074
Closed -$160K – 3448
2025
Q2 		$160K Sell
3,074
-107
-3% -$4.78K ﹤0.01% 2399
2025
Q1 		$136K Sell
3,181
-22,353
-88% -$964K ﹤0.01% 2821
2024
Q4 		$780K Sell
25,534
-19,309
-43% -$543K ﹤0.01% 999
2024
Q3 		$1.03M Buy
+44,843
New +$1.27M ﹤0.01% 1064
2024
Q1 		– Sell
-22,778
Closed -$616K – 3146
2023
Q4 		$616K Sell
22,778
-4,823
-17% -$127K 0.01% 1337
2023
Q3 		$818K Buy
+27,601
New +$971K 0.01% 1438
2023
Q2 		– Sell
-15,027
Closed -$352K – 2613
2023
Q1 		$352K Sell
15,027
-9,382
-38% -$268K ﹤0.01% 1992
2022
Q4 		$664K Sell
24,409
-41,446
-63% -$1.9M 0.01% 1297
2022
Q3 		$3.54M Buy
65,855
+24,053
+58% +$1.23M 0.04% 345
2022
Q2 		$1.69M Buy
41,802
+11,001
+36% +$545K 0.02% 846
2022
Q1 		$2.04M Sell
30,801
-39,079
-56% -$2.67M 0.02% 903
2021
Q4 		$6.99M Sell
69,880
-904
-1% -$93.5K 0.04% 372
2021
Q3 		$8.85M Buy
70,784
+5,821
+9% +$692K 0.04% 309
2021
Q2 		$8.07M Buy
64,963
+58,845
+962% +$7.92M 0.04% 423
2021
Q1 		$934K Buy
6,118
+3,184
+109% +$481K ﹤0.01% 1592
2020
Q4 		$378K Sell
2,934
-5,064
-63% -$583K ﹤0.01% 2199
2020
Q3 		$894K Sell
7,998
-1,914
-19% -$175K 0.01% 1247
2020
Q2 		$804K Buy
9,912
+6,841
+223% +$551K 0.01% 1631
2020
Q1 		$214K Sell
3,071
-3,505
-53% -$269K ﹤0.01% 2457
2019
Q4 		$514K Sell
6,576
-1,368
-17% -$98.6K ﹤0.01% 1750
2019
Q3 		$507K Buy
+7,944
New +$700K ﹤0.01% 1881
2019
Q2 		– Sell
-1,410
Closed -$108K – 3210
2019
Q1 		$108K Buy
+1,410
New +$78.2K ﹤0.01% 3018

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

SG Americas Securities's GH Position: Q2 2026 in Review

SG Americas Securities increased its Guardant Health (GH) stake by 63% in Q2 2026, buying an estimated $1.53M and bringing the position to 36,270 shares worth $5.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1055.

SG Americas Securities first reported a position in GH in Q1 2019 and has held it in 25 quarters since. The position peaked at $8.85M in Q3 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • SG Americas Securities held 36,270 shares of Guardant Health worth $5.44M as of Q2 2026.
  • SG Americas Securities bought 14,026 Guardant Health shares in Q2 2026, an estimated $1.53M.
  • Guardant Health made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1055 holding.
  • SG Americas Securities first reported a position in Guardant Health in Q1 2019 and has held it in 25 quarters since.
  • SG Americas Securities's Guardant Health position peaked at $8.85M in Q3 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.